George B. Moore is a partner of Juniper Investment Company, a New York-based private investment firm that invests as an active, long-term, lead shareholder in a concentrated portfolio of US public equity securities. Juniperās healthcare investments have included Artivion (AORT), Bioventus (BVS), Transcat (TRNS), and Theragenics.
Mr. Moore has over 25 years of public and private equity investing experience. During this time has been responsible for sourcing, due diligence, investment approval, execution, value-add, and board oversight of numerous public and private company investments. This experience includes extensive transactional expertise, including mergers and tuck-in acquisitions, IPOs, debt and equity offerings, and bank financings. Prior to joining Juniper, Mr. Moore was a partner of Quilvest Private Equity, managing partner of Bristlecone LLC, vice president of Hoak Capital, and analyst at Citicorp Venture Capital. Mr. Moore received his B.A. from Colby College and his M.B.A. from Columbia Business School.